Literature DB >> 2400911

Reactive microglia express class I and class II major histocompatibility complex antigens in Alzheimer's disease.

I Tooyama1, H Kimura, H Akiyama, P L McGeer.   

Abstract

Expression of major histocompatibility complex (MHC) class I (HLA-A,B,C) and class II (HLA-DR) antigens was studied in postmortem brain tissue of Alzheimer's disease and age-matched control cases. Monoclonal antibodies to class I antigens stained reactive microglia weakly to moderately and vascular endothelial cells strongly in Alzheimer's gray and white matter. Capillaries were also stained strongly in control brains, but only a few positively stained microglia could be observed in white matter. In Alzheimer cases, HLA-DR positive reactive microglia were more numerous and more strongly staining than MHC class I positive reactive microglia but many cells appeared to express both classes of antigen. Rare large cells of uncertain origin also stained positively for class I. Double immunostaining established that MHC class I positive cells were a separate population from glial fibrillary acidic-protein-positive astrocytes.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2400911     DOI: 10.1016/0006-8993(90)91496-4

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  37 in total

Review 1.  Microglia in Health and Disease.

Authors:  Richard M Ransohoff; Joseph El Khoury
Journal:  Cold Spring Harb Perspect Biol       Date:  2015-09-09       Impact factor: 10.005

2.  Microglial TNF-α-dependent elevation of MHC class I expression on brain endothelium induced by amyloid-beta promotes T cell transendothelial migration.

Authors:  Yi-Ming Yang; De-Shu Shang; Wei-Dong Zhao; Wen-Gang Fang; Yu-Hua Chen
Journal:  Neurochem Res       Date:  2013-08-29       Impact factor: 3.996

3.  Arginine deprivation and immune suppression in a mouse model of Alzheimer's disease.

Authors:  Matthew J Kan; Jennifer E Lee; Joan G Wilson; Angela L Everhart; Candice M Brown; Andrew N Hoofnagle; Marilyn Jansen; Michael P Vitek; Michael D Gunn; Carol A Colton
Journal:  J Neurosci       Date:  2015-04-15       Impact factor: 6.167

4.  Progressive expression of immunomolecules on microglial cells in rat dorsal hippocampus following transient forebrain ischemia.

Authors:  T Morioka; A N Kalehua; W J Streit
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

5.  Inflammatory changes parallel the early stages of Alzheimer disease.

Authors:  A Parachikova; M G Agadjanyan; D H Cribbs; M Blurton-Jones; V Perreau; J Rogers; T G Beach; C W Cotman
Journal:  Neurobiol Aging       Date:  2006-10-18       Impact factor: 4.673

6.  Immunohistochemical study of a case with progressive supranuclear palsy without ophthalmoplegia.

Authors:  E Kida; M Barcikowska; M Niemczewska
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

Review 7.  Microglia in Alzheimer's disease.

Authors:  Heela Sarlus; Michael T Heneka
Journal:  J Clin Invest       Date:  2017-09-01       Impact factor: 14.808

Review 8.  Inflammatory mechanisms in neurodegeneration.

Authors:  Michael R Nichols; Marie-Kim St-Pierre; Ann-Christin Wendeln; Nyasha J Makoni; Lisa K Gouwens; Evan C Garrad; Mona Sohrabi; Jonas J Neher; Marie-Eve Tremblay; Colin K Combs
Journal:  J Neurochem       Date:  2019-03-27       Impact factor: 5.372

9.  Abnormal activation of microglia accompanied with disrupted CX3CR1/CX3CL1 pathway in the brains of the hamsters infected with scrapie agent 263K.

Authors:  Wu-Ling Xie; Qi Shi; Jin Zhang; Bao-Yun Zhang; Han-Shi Gong; Yan Guo; Shao-Bin Wang; Yin Xu; Ke Wang; Cao Chen; Yong Liu; Xiao-Ping Dong
Journal:  J Mol Neurosci       Date:  2013-03-24       Impact factor: 3.444

10.  Inflammation in Alzheimer's disease: relevance to pathogenesis and therapy.

Authors:  Elina Zotova; James Ar Nicoll; Raj Kalaria; Clive Holmes; Delphine Boche
Journal:  Alzheimers Res Ther       Date:  2010-01-22       Impact factor: 6.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.